HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical Therapy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorÖmer Faruk Okumuş

About this trial

This observational clinical study aims to investigate the relationship between the HALP score (Hemoglobin × Albumin × Lymphocyte / Platelet), several blood-based inflammatory indices (including NLR, PLR, LMR, and SII), and salivary MMP-8 levels in individuals with periodontal health, gingivitis, and stage III/IV periodontitis. The study also evaluates how these biomarkers relate to healing following non-surgical periodontal therapy.

A total of 180 participants aged 18-65 years will be included: 50 healthy individuals, 50 patients with gingivitis, and 80 patients with stage III/IV periodontitis. All participants will undergo periodontal clinical examination and provide blood and saliva samples at baseline. Individuals in the gingivitis and periodontitis groups will receive standard non-surgical periodontal treatment (full-mouth debridement) and will return for a 3-month follow-up visit, where periodontal measurements will be repeated. In the periodontitis group, an additional blood sample will be collected at the 3-month follow-up visit.

The primary objective is to determine whether baseline HALP score, systemic inflammatory indices, and salivary MMP-8 levels differ between participants who show good versus poor healing after treatment. Secondary objective include comparing biomarker levels across periodontal status groups. The findings may contribute to early prediction of treatment response and personalized periodontal care.

Eligibility criteria

Qualifiers

Adults aged 18-65 years

Ability to provide informed consent

No systemic diseases or conditions affecting periodontal status

For Healthy Group: Probing depth ≤3 mm, no attachment loss, no radiographic bone loss

Disqualifiers

Systemic diseases influencing periodontal inflammation (e.g., diabetes, autoimmune disorders)

Current pregnancy or lactation

Use of antibiotics, anti-inflammatory medications, or immunosuppressive drugs within the last 3 months

Smokers or individuals using tobacco products

Trial design

Treatments tested in this trial

  • Non-surgical Periodontal Therapy

Treatment groups

180 Participants
are divided into 3 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Erzincan Binali Yıldırım University Faculty of DentistryRecruiting24002, Merkez, ErzincanTurkey (Türkiye)

Sponsors and collaborators

Ömer Faruk Okumuş

Lead sponsor

Erzincan University

Sponsor institution

Erzincan Binali Yildirim Universitesi

Collaborator